Introduction

46
The use of non-human primates as experimental animal models is highly effective for 47 research on human diseases. Non-human primates and humans share comparable 
In vivo depletion of CD8 + T lymphocytes 107
In vivo depletion of the marmoset CD8 + T lymphocytes was performed as 108 previously described [19] . Briefly, the 6F10 or a control mAb (MOPC-21) was 109 administrated subcutaneously to the subject at 10 mg/kg (body weight) followed by 110 intravenous administration at 5 mg/kg in the saphenous vein at a rate of 20 ml/h using 111 a syringe pump on days 3, 7, 10 after the primary administration. by 10 ng or more of 6F10 mAb ( Fig.2A) . We then sought to define whether the reduced by the pretreatment of 10 or 100 ng 6F10 (Fig. 2B, C) . On the other hand, the 147 6F10 pretreatment scarcely influenced fluorescence intensity in the cells that reacted 148 with the labeled T8 mAb, irrespective of the amounts of 6F10 (Fig. 2B, C by gradual recovery to a half of the initial levels at around 4-7 weeks later (Fig. 3) . It is 
CD3
-CD20 -cells were scarcely affected (Fig. 4) . In addition, administration of a 167 control antibody (MOPC-21) did not affect any lymphocyte subsets (data not shown).
168
These results demonstrated that the 6F10 mAb was able to specifically deplete CD8 + T 169 cells in marmosets. 
Discussion
171
In this study, we attempted to establish a technical basis for the study of CD8 erythrocytes were lysed and the stained cells were resuspended in the fix buffer.
226
Representative results in a marmoset are shown. The G1 lymphocyte population was 227 selected (left top panel) and a CD3 + T cell subset was gated (right top panel).
228
Fluorescence intensity for CD4 and CD8 in the T cell subset was depicted (lower 229 panels). were different in each antibody by using StatView software. 
